Search results
Toddler's Snoring Turned Out to Be an Early Sign of Leukemia: 'We Were All Sobbing'
People via Yahoo News· 5 days agoAccording to the Mayo Clinic, this type of cancer affects the blood and bone marrow — the...
After nearly 30 years at Coastal Carolina, what will Gary Gilmore do after baseball?
The Post and Courier· 22 hours agoOf course, his own battles with cancer have given him insight and perspective exclusive to those...
The price of hope: CAR-T therapy in pediatric leukemia
Medical Xpress· 2 days agoWe stand at the crossroads of medical innovation, where cutting-edge scientific discoveries...
North Crawford High School Band performs song for seven-year-old based on her book of surviving...
WKBT La Crosse· 6 days agoNORTH CRAWFORD, (WKBT)-- Ruby Ihm was only three years old when she was diagnosed with cancer. For...
Cancer Survivors Are Sharing Their First Cancer Symptoms, And As A Hypochondriac, I Am Calling My...
BuzzFeed via Yahoo News· 6 days ago"Moral of the story: GET IT CHECKED!!! If the doctor pooh-poohs it, get it checked by a different...
Miracle Kids: Remi Anthony
13WHAM Rochester· 21 hours agoLike most 3-year-olds, Remi Anthony is always on the move. It seemed like a routine case of hand, foot and mouth disease. "I just felt pretty...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
CBS 47 Fresno· 7 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the ...
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
Zacks via Yahoo Finance· 5 days agoAmgen, Imdelltra, which is a targeted bispecific therapy, marks a major advancement in the SCLC ...
The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below...
Nature· 5 days agoDetection of measurable residual disease (MRD) in hematological malignancies is crucial for prognostication and treatment decisions. Real-time quantitative PCR (RQ-PCR), which ...
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 12 hours agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.